Stocky
TMDX
TransMedics Group, Inc.
NASDAQ NMS - GLOBAL MARKET · Health Care · US
76.49
▼ -5.28%

What's happening at TransMedics Group, Inc.

TransMedics Group, Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 4 Aug 2026

Company reports Q2 2026 financial results on August 4

Quarterly earnings show how well the company is performing and whether it is growing revenue or profits.

SEC 10-Q · filed 2026-08-04 View filing ↗
Governance 4 Aug 2026

Shareholders elect eight directors at May 2026 annual meeting

Directors make important decisions about the company, so who is elected matters to investors.

SEC 8-K · filed 2026-08-04 View filing ↗
Earnings 21 May 2026

Company reports Q1 2026 financial results on May 5

Quarterly earnings show how well the company is performing and whether it is growing revenue or profits.

SEC 8-K · filed 2026-05-21 View filing ↗
Earnings 5 May 2026

Company announces tax valuation allowance release impact on 2025 results

Changes to tax accounting can significantly affect reported profits and what the company owes in taxes.

SEC 10-Q · filed 2026-05-05 View filing ↗
Earnings 5 May 2026

TransMedics files 2025 annual report on February 24

Annual reports show the full year results and explain how the company manages money and risks.

SEC 8-K · filed 2026-05-05 View filing ↗
Earnings 27 Feb 2026

Reported its financial results

SEC 8-K · filed 2026-02-27 View filing ↗
Earnings 24 Feb 2026

Filed its annual report

SEC 10-K · filed 2026-02-24 View filing ↗

Common questions

How does Stocky track TransMedics Group, Inc.'s company events?

Stocky reads TransMedics Group, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was TransMedics Group, Inc.'s most recent SEC filing?

TransMedics Group, Inc.'s most recent tracked filing was a 10-Q on 4 Aug 2026: Company reports Q2 2026 financial results on August 4.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See TransMedics Group, Inc.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.